Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals after the Initiation of HBV‐Active Antiretroviral Therapy
Author(s) -
Megan Crane,
Ben Oliver,
Gail Matthews,
Anchalee Avihingsa,
Sasiwimol Ubolyam,
Vesna Celeva Markovska,
J. Judy Chang,
Gregory J. Dore,
Patricia Price,
Kumar Visvanathan,
Martyn A. French,
Kiat Ruxrungtham,
Sharon R. Lewin
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/597276
Subject(s) - virology , antiretroviral therapy , medicine , hepatitis b virus , human immunodeficiency virus (hiv) , hepatitis b , immunology , virus , viral load
The pathogenesis of and risk factors for hepatic flare (HF) after the initiation of hepatitis B virus (HBV)-active antiretroviral therapy (ART) in HIV/HBV-coinfected individuals is not well understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom